MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
|
journal
|
November 2010 |
Promising tumor-associated antigens for future prostate cancer therapy: TAAs AS POTENTIAL THERAPEUTIC TARGETS
|
journal
|
June 2009 |
RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo
|
journal
|
August 2005 |
Profiling and Verification of Gene Expression Patterns in Normal and Malignant Human Prostate Tissues by cDNA Microarray Analysis
|
journal
|
January 2001 |
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
|
journal
|
January 2004 |
Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein
|
journal
|
December 2002 |
Influence of MUC1 genetic variation on prostate cancer risk and survival
|
journal
|
July 2008 |
A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients
|
journal
|
February 2012 |
The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers
|
journal
|
June 2008 |
Gene therapy for cancer and metastatic disease
|
journal
|
June 2003 |
Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma
|
journal
|
June 2002 |
Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
|
journal
|
October 2011 |
Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
|
journal
|
January 2011 |
Gene expression analysis of prostate cancers
|
journal
|
January 2002 |
The Discovery of Putative Urine Markers for the Specific Detection of Prostate Tumor by Integrative Mining of Public Genomic Profiles
|
journal
|
December 2011 |
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion
|
journal
|
January 2012 |
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
|
journal
|
January 2009 |
Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts
|
journal
|
September 2009 |
Regulation of a Late Phase of T Cell Polarity and Effector Functions by Crtam
|
journal
|
March 2008 |
Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells
|
journal
|
January 2005 |
Interleukin-6 Polymorphism is Associated with more Aggressive Prostate Cancer
|
journal
|
August 2005 |
Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
|
journal
|
January 2010 |
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer
|
journal
|
March 2006 |
Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis
|
journal
|
June 2003 |
Cancer statistics, 2012
|
journal
|
January 2012 |
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
|
journal
|
August 2011 |
Basal prostate epithelial cells stimulate the migration of prostate cancer cells
|
journal
|
January 2004 |
Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis
|
journal
|
January 2003 |
Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
|
journal
|
July 1997 |
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
|
journal
|
February 2009 |
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
|
journal
|
January 2010 |
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions
|
journal
|
August 2003 |
Treatment and prevention of bone complications from prostate cancer
|
journal
|
January 2011 |
Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells
|
journal
|
April 2012 |
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
|
journal
|
June 2011 |
Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer: Sp/KLF Family in Cell Growth and Cancer
|
journal
|
June 2001 |
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
|
journal
|
November 1994 |
Use of Desmin Immunohistochemistry To Distinguish Between Mesothelial Cells and Carcinoma in Serous Fluid Cell Block Preparations
|
journal
|
January 2000 |
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
|
journal
|
December 2012 |
55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor
|
journal
|
May 2003 |
A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
|
journal
|
May 2011 |
Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage
|
journal
|
January 2012 |
Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer
|
journal
|
May 2012 |
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
|
journal
|
June 2010 |
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival
|
journal
|
December 2002 |
Delineation of prognostic biomarkers in prostate cancer
|
journal
|
August 2001 |
Genomic Structure and DNA Binding Properties of the Human Zinc Finger Transcriptional Repressor AP-2rep (KLF12)
|
journal
|
February 2000 |
MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy
|
journal
|
May 2007 |
FGFR1 and WT1 are markers of human prostate cancer progression
|
journal
|
November 2006 |
Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies
|
journal
|
April 2002 |
Immunohistochemical detection of WT1 protein in a variety of cancer cells
|
journal
|
March 2006 |
Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro
|
journal
|
January 2001 |
Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin
|
journal
|
October 1995 |
Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression
|
journal
|
April 2009 |
mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: Valuable tool for risk assessment and prevention trials
|
journal
|
February 2010 |
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
|
journal
|
March 2009 |
Prostate Cancer-Associated Gene Expression Alterations Determined from Needle Biopsies
|
journal
|
April 2009 |
A causal role for ERG in neoplastic transformation of prostate epithelium
|
journal
|
February 2008 |
WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study
|
journal
|
April 2006 |
Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine
|
journal
|
January 2012 |
Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour–stroma interactions
|
journal
|
March 2008 |
Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts
|
journal
|
January 2009 |
A Role for the G 12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion
|
journal
|
June 2006 |
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
|
journal
|
January 2009 |
β-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1
|
journal
|
January 2008 |
Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection
|
journal
|
April 2010 |
SPARC Inhibits LPA-Mediated Mesothelial—Ovarian Cancer Cell Crosstalk
|
journal
|
January 2007 |
A Diagnostic Test for Prostate Cancer From Gene Expression Profiling Data
|
journal
|
February 2004 |
Expression of the Survivin Gene in Prostate Cancer: Correlation With Clinicopathological Characteristics, Proliferative Activity and Apoptosis
|
journal
|
May 2004 |
Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies
|
journal
|
November 2009 |
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
|
journal
|
May 2012 |
Genetic determinants of cancer metastasis
|
journal
|
May 2007 |
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance — A study of the OVCAD consortium
|
journal
|
January 2013 |
Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
|
journal
|
June 2009 |
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer: Single-Cell Analysis of Circulating Tumor Cells Identifies Cumulative
|
journal
|
December 2012 |
The urokinase-type plasminogen activator system in cancer metastasis: A review
|
journal
|
July 1997 |
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
|
journal
|
March 2006 |
Positive- and Negative-acting Krüppel-like Transcription Factors Bind a Transforming Growth Factor β Control Element Required for Expression of the Smooth Muscle Cell Differentiation Marker SM22α in Vivo
|
journal
|
August 2000 |
Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
|
journal
|
August 2012 |
Genome-wide Profiling of RNA splicing in prostate tumor from RNA-seq data using virtual microarrays
|
journal
|
January 2012 |
Co-evolution of tumor cells and their microenvironment
|
journal
|
January 2009 |
MUC1 as a Putative Prognostic Marker for Prostate Cancer
|
journal
|
January 2008 |
TGF-β1 Reverses Inhibition of COX-2 With NS398 and Increases Invasion in Prostate Cancer Cells
|
journal
|
May 2010 |
Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
|
journal
|
May 2008 |
MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer
|
journal
|
November 2005 |
Molecular mechanisms of metastasis in prostate cancer
|
journal
|
December 2008 |
Steps in prostate cancer progression that lead to bone metastasis
|
journal
|
March 2011 |
Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis
|
journal
|
August 2006 |
Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
|
journal
|
June 2010 |
Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines
|
journal
|
December 2002 |
Targeting Aurora Kinases for the Treatment of Prostate Cancer
|
journal
|
May 2006 |
RECK overexpression decreases invasive potential in prostate cancer cells
|
journal
|
October 2011 |
MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines
|
journal
|
April 2011 |
Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer☆
|
journal
|
November 2006 |
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
|
journal
|
May 2013 |
Genomic Alterations Indicate Tumor Origin and Varied Metastatic Potential of Disseminated Cells from Prostate Cancer Patients
|
journal
|
July 2008 |
Cross-Talk between the Interleukin-6 and Prostaglandin E2 Signaling Systems Results in Enhancement of Osteoclastogenesis through Effects on the Osteoprotegerin/Receptor Activator of Nuclear Factor-κB (RANK) Ligand/RANK System
|
journal
|
April 2005 |
High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma
|
journal
|
September 2007 |
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
|
journal
|
October 2012 |
Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect
|
journal
|
October 2010 |
Suppression of Prostate Carcinoma Cell Invasion by Expression of Antisense L-Plastin Gene
|
journal
|
July 1999 |
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
|
journal
|
October 2010 |
The translational landscape of mTOR signalling steers cancer initiation and metastasis
|
journal
|
February 2012 |
Downregulation of several fibulin genes in prostate cancer
|
journal
|
January 2007 |
Molecular Pathways Involved in Prostate Carcinogenesis: Insights from Public Microarray Datasets
|
journal
|
November 2012 |
WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study: WT1 Gene as MRD Marker in AML
|
journal
|
April 2004 |
Up-regulation of Wnt-1 and ?-catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications
|
journal
|
January 2004 |
Integrative analysis of the melanoma transcriptome
|
journal
|
February 2010 |
Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators
|
journal
|
June 1996 |
A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines
|
journal
|
November 2002 |
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
|
journal
|
December 2010 |
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|
journal
|
December 2007 |
Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays
|
journal
|
January 2003 |
The “seed and soil” hypothesis revisited
|
journal
|
August 2008 |
A comparison of analog and Next-Generation transcriptomic tools for mammalian studies
|
journal
|
March 2011 |
The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
|
journal
|
January 2013 |
IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells
|
journal
|
November 2003 |
Clusterin Mediates TGF- -Induced Epithelial-Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells
|
journal
|
August 2012 |
Caveolin-1 Expression Inhibits Wnt/β-Catenin/Lef-1 Signaling by Recruiting β-Catenin to Caveolae Membrane Domains
|
journal
|
May 2000 |
Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells
|
journal
|
August 2011 |
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases
|
journal
|
October 2007 |
Serum Level of Clusterin and Its Density in Men with Prostate Cancer as Novel Biomarkers Reflecting Disease Extension
|
journal
|
February 2010 |
LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
|
journal
|
April 2009 |
Transcriptome sequencing to detect gene fusions in cancer
|
journal
|
January 2009 |
Innate immunity in early chordates and the appearance of adaptive immunity
|
journal
|
June 2004 |
N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer
|
journal
|
August 2009 |
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
|
journal
|
May 2012 |
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases
|
journal
|
January 2005 |
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
|
journal
|
March 2009 |
Metastasis: recent discoveries and novel treatment strategies
|
journal
|
May 2007 |
Regulation of Osteoclast Differentiation
|
journal
|
April 2006 |
Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients
|
journal
|
January 2011 |
RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer
|
journal
|
September 2007 |
Blood-Based Biomarkers of Aggressive Prostate Cancer
|
journal
|
September 2012 |
SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells: SPARC actions on periodontal ligament cells
|
journal
|
July 2002 |
The Multifaceted Roles of Osteopontin in Cell Signaling, Tumor Progression and Angiogenesis
|
journal
|
December 2006 |
Immunohistochemical Analysis of Nuclear Versus Cytoplasmic Staining of WT1 in Malignant Mesotheliomas and Primary Pulmonary Adenocarcinomas
|
journal
|
October 2001 |
The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells
|
journal
|
October 2009 |